Day: January 17, 2025

For several decades, aspirin has played a key role in the treatment of cardiovascular diseases. While its effectiveness in secondary prevention—meaning after a heart attack, stroke, or other vascular complication—is well-established, its use in primary prevention for individuals without prior history remains controversial.
This duality raises significant questions about the benefits and risks of aspirin, particularly regarding the delicate balance between the cardiovascular protection it offers and potential complications, such as bleeding.